Instituto COI de Educacao e Pe /ID# 200499

Rio de Janeiro 22793-080

0 studies enrolling now · 1 studies all time

What they study most

Small Cell Lung Cancer

Studies at this site

• Study Evaluating the Safety of Rovalpituzumab Tesirine for Third-Line and Later Treatment of Subjects With Relapsed or Refractory Small Cell Lung Cancer — Withdrawn before enrolling